newsfilter
← Latest News
PR Newswire·

Theseus Pharmaceuticals Announces Closing of Tender Offer

Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus" or the "Company"), a clinical-stage biopharmaceutical company focused on improving the lives...